Synthesis reveals antibacterial properties of new dibenzoquinazoline derivatives, indicating potential medical applications.
Condensation of 3-benzyl-2-thioxo-2,3-dihydro-1-spiro[benzo[]quinazoline-5,1'-cycloheptane]-4(6)-one with 5,5-dialkyl-2-chloromethylbenzo[]quinazolines were used to synthesize dibenzo[]quinazoline compounds in which spiro[benzo[]quinazoline-5,1'-cycloheptane] in the second position is linked via a -SCH- linker to another benzo[]quinazoline molecule. The specified 2-thioxobenzo[]quinazoline, under similar conditions, upon reaction with methylene iodide, forms 2,2'-[(methylenebis(sulfandilyl))]bis[3-benzyl-3-spiro[benzo[]quinazoline-5,1'-cycloheptane]]-4(6)-one. A transition was made from the starting benzo[]quinazoline to the 2-hydrozimoderivative, which is cleaved in the presence of caustic potash to form 3-benzyl-3-spiro[benzo[]quinazoline-5,1'-cycloheptane]-4(6)-one. Based on the 2-hydrozimo derivative, hydrazone, thiosemicarbazide, and 4-benzyl-4-spiro[benzo[][1,2,4]triazolo[4,3-]quinazoline-6,1'-cycloheptanoenes] have been synthesized. Condensation of 4-benzyl-1-mercapto-4-spiro[benzo[][1,2,4]triazolo[4,3-]quinazoline-6,1'-cycloheptane]-5(7)-one with alkyl halides 1-sulfanyl-substituted triazolobenzo[]quinazoline derivatives of various structures were obtained. The antibacterial properties of the synthesized compounds were studied.
No takes yet. Share an insight, caveat, or question.
A. I. Markosyan (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: